Late phases studies overview
Since 2015, we have been organizing and conducting scientific, preclinical, and clinical studies of medicinal products and medical devices.
To date, we have successfully conducted over 53 late-phase clinical studies across 27 therapeutic areas.
One of the key directions of our work is clinical vaccine trials. Our experience includes conducting large-scale studies of vaccines against COVID-19, pneumococcal and meningococcal infections, influenza, Middle East Respiratory Syndrome (MERS), tuberculosis, SARS, and other diseases with the participation of thousands of volunteers. Our specially designed Vaccine Fast Track approach utilizes advanced algorithms and data-driven forecasting to accelerate studies without compromising quality.